Skip to content

A prospective randomized controlled clinical study on the rapid rehabilitation of radical resection patients with high risk prostate cancer by taking carbohydrate before surgery

A prospective randomized controlled clinical study on the rapid rehabilitation of radical resection patients with high risk prostate cancer by taking carbohydrate before surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012867
Enrollment
Unknown
Registered
2017-10-01
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

experimental group:preoperative carbohydrate

Sponsors

Shanghai Tenth People's Hospital, Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients with radical resection of prostate cancer; 2. Patients with initial treatment; 3. Hospitalized patients aged 45 to 80 years; 4. Patients who are willing to sign informed consent; 5. Fasting for 8 to 12 hours before surgery, and abstinence for 2 hours; 6. Postoperative hospital stay time was more than 72 hours; 7. Patients who dont have a sugar solution.

Exclusion criteria

Exclusion criteria: 1. Patients diagnosed with diabetes and other severe metabolic diseases; 2. Patients with emergency surgery; 3. Patients with gastric emptying obstruction, complete digestive tract complete obstruction and unable to use enteral preparations; 4. Patients with high risk of severe cardiac renal dysfunction may influence the evaluation of safety evaluation; 5. Mental disorders, alcohol dependence, and drug abuse history; 6. Lactation and pregnancy; 7. Allergies or previous allergy to a variety of drugs, maltodextrin fructose; 8. Participated in other clinical researchers three months prior to the trial; 9. Other researchers consider it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
rapid rehabilitation;subjective comfort;

Secondary

MeasureTime frame
cortisol;cellular immunity;Liquid immunity;TNF;CRP;

Countries

China

Contacts

Public ContactWANG FEN

Shanghai Tenth People's Hospital, Tongji University School of Medicine

fenfen1007@126.com+86 13701674783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026